Pimobendan inhibits the activation of transcription factor NF-kappa B - A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase
A. Matsumori et al., Pimobendan inhibits the activation of transcription factor NF-kappa B - A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase, LIFE SCI, 67(20), 2000, pp. 2513-2519
Pimobendan, an inhibitor of phosphodiesterase III with calcium sensitizing
properties, inhibits the production of cytokines and nitric oxide. In the p
resent study, the effects of pimobendan and other inotropic agents on the a
ctivation of transcription factor NF-kappa B were examined. Pimobendan sign
ificantly decreased the expression of luciferase protein in A549 cells tran
sfected with the NF-kappa B reporter plasmid, stimulated with interleukin (
LL)-1 beta, tumor necrosis factor-alpha, or phorbol 12-myristate 13 acetate
. However, high concentrations of amrinone, vesnarinone, or NKH 477 decreas
ed promoter activity only slightly. Electrophoretic mobility shift assay al
so showed inhibition of NF-kappa B activation by pimobendan. Pimobendan pos
sesses the unique property of inhibiting NF-kappa B, which may be independe
nt of phosphodiesterase inhibition. (C) 2000 Elsevier Science Inc. All righ
ts reserved.